Chuck Z Li

A rational approach to assess off-target reactivity of a dual-signal integrator for T cell therapy.

A. Kamb, Rabi Murad, D. Warshaviak, 2022, Toxicology and applied pharmacology.

A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo

A. Kamb, M. Sandberg, Xueyin Wang, 2022, Science Translational Medicine.

122 A powerful, precise targeting system controlled by tumor deletions transforms CEA and MSLN CAR-T cells into tumor-selective agents

Aaron J. Martin, A. Kamb, Shruti Sharma, 2021, Journal for ImmunoTherapy of Cancer.

229 A2B530, an autologous CEA-directed Tmod T-cell therapy with an inhibitory receptor gated by HLA-A*02 to target colorectal, pancreatic, and lung cancer

D. Maloney, M. Borad, T. Welling, 2022, Regular and Young Investigator Award Abstracts.